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Chronic urticaria, defined as widespread daily or nearly
daily wheals for at least 6 weeks, with or without angioe-
dema, impacts on patients’ quality of life. Natural course is
self-limited, with spontaneous remissions and occasional
relapses. Antihistamines, leukotriene inhibitor, immuno-
suppressive agents are used. 60% are idiopathic and 40%
are autoimmune due to presence of anti-IgE antibody or
IgG autoantibodies against Fc∑R1. An association exists
between chronic urticaria and autoimmune diseases. We
report a case of a patient with autoimune urticaria, thyroid
disease and vitiligo, who showed resolution of histamine
releasing antibody (reflab) on remission.
In February 2005, a 44 yr old healthy woman was
referred to the Allergy outpatient clinic with two month
history of daily hives, moderately controlled with antihis-
tamines, with good response to oral steroid. Lesions were
pruritic, raised, erythematous, lasting for < 24 hrs and
resolved with purplish discoloration. Screening negative
for malignancy, connective tissue disease. TSH normal.
Histamine releasing antibody positive, maximum hista-
mine release 27% (<16%). Skin biopsy confirmed chronic
urticaria with neutrophils without vasculitis. Sulfasalazine
was not tolerated, but control attained with antihista-
mines and leukotriene inhibitor. By one year, she failed
trial of weaning medications.
6 months after presentation she developed vitiligo. 5
years later, she was hypothyroid. By 3 years, the urticaria
was in complete remission without medications. Repeat
histamine releasing antibody was negative.
There is a known association of severe chronic urti-
caria with auto antibody etiology and other autoimmune
disease. Does resolution of antibody correlate with
achieving remission? Further prospective studies are
required to establish this relationship.
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